Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Chondrocyte Enlargement Sheds New Light on Cell Volume Regulation

Lara C. Pullen, PhD  |  May 2, 2013

Up until now, scientists have had little understanding of the molecular mechanisms behind chondrocyte enlargement or the regulation of final cell size. An understanding of the cellular processes would be one step towards modulating the growth of individual elements within an organism.

A study, published in the March 21 issue of Nature, describes the regulation of skeletal size and explores how cells sense, modify, and establish a volume set point.1 Kimberly L. Cooper, PhD, of Harvard Medical School in Boston, and her colleagues describe the multiphase process by which cell swelling allows chondrocytes to rapidly enlarge while at the same time minimizing the energetic cost of growth.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“It was expected that these cells [hypertrophic chondrocytes] enlarged by swelling, but it was very controversial,” elaborates Dr. Cooper. While plant cells are known to swell, animal cells are characterized by tight fluid regulatory mechanisms.

In order to visualize the cell swelling, the authors utilized diffraction phase microscopy and measured the dry mass of live cells they dissociated from growth plate cartilage. In addition to measuring cell size and dry mass, the authors also looked at the effects of Igf1 on the different phases of volume enlargement.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

They identified three phases of chondrocyte cell growth. In the first phase, the cell maintains its initial high density of dry mass. This phase represents true hypertrophy—a proportionate increase in dry mass production and fluid uptake. In the second phase, individual chondrocytes swell by taking in extra fluid. In the third phase, they continue to increase in size while maintaining the low density first established in phase two. The duration of the final phase of volume enlargement can occur rapidly and the speed distinguishes rapidly and slowly elongating growth plates.

For example, within the same animal, the rapidly elongating proximal tibia contains large hypertrophic chondrocytes, whereas the slowly elongating proximal radius contains smaller hypertrophic chondrocytes. When the authors compared the hind limbs of two different species, the mouse and the jerboa (a rodent with elongated hind limbs), they found that, while the hypertrophic chondrocytes in the proximal tibia are similar between the two species, the metatarsal chondrocytes are strikingly different. The elongated hind limbs had individual hypertrophic chondrocytes that were 58% larger than those of the mouse.

The authors discovered that the third phase is regulated locally and is dependent of insulin-like growth factor (IGF). The data also suggest that growth plate–dependent cell size may be dependent on Igf1. “This is a kind-of unique look at the role of IGF-1 locally,” says Dr. Cooper.

Page: 1 2 | Single Page
Share: 

Filed under:Research Rheum Tagged with:bone growthchondrocyte

Related Articles

    Basics of Biologic Joint Reconstruction

    April 6, 2012

    For young patients especially, this can delay knee replacement and provide better outcomes.

    New Insights into CPPD

    October 1, 2013

    Progress in research, outcomes, diagnosis, and treatment of calcium pyrophosphate dihydrate crystal deposition disease

    Case Report: A Patient’s Clubbing & Arthralgias Resist Diagnosis

    April 15, 2020

    A 59-year-old woman presented to our rheumatology clinic with a six-month history of a symmetric polyarthritis. She initially experienced pain in both knees. As time progressed, she began to notice pain in her ankles, hips, shoulders, hands and feet. She experienced joint stiffness lasting for more than 30 minutes every morning. She also described worsening…

    A&R Abstracts – ADIPOKINES

    August 1, 2011

    For Further Reading

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences